AviadoBio Website
6 known investors
AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.
Founders & leadership
CS
Chris ShawCo-Founder & Chief Scientific and Clinical Advisor
DY
Do Young LeeCo-Founder
YB
Youn Bok LeeCo-Founder
LD
Lisa DeschampsChief Executive Officer
GF
Graeme FielderChief Operating Officer
AB
Alex BloomChief Development Officer
DC
David CooperChief Medical Officer
FS
Farah SpeerSVP, Communications & External Relations
JI
John IsaacChief Scientific Officer
Investors Β· 6
Frequently asked questions
- What does AviadoBio Website do?
- AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.
- Who founded AviadoBio Website?
- AviadoBio Website was founded by Chris Shaw, Do Young Lee, Youn Bok Lee.
- Who are AviadoBio Website's investors?
- AviadoBio Website's investors include Advent Life Sciences, Dementia Discovery, F-Prime Capital, LifeArc Ventures, Monograph Capital Partners, New Enterprise Associates (NEA).